Andrew J. Deans

Andrew J. Deans

Auto-generated profile, based on publicly available information

Andrew J. Deans

St Vincents Institute of Medical Research

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2011 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
ADAndrew J. Deans
Andrew J. Deans
SWStephen West
Stephen West

1 November 2015 in Molecular Cell
Verified
Journal Article
Open access
RSRebekka A. Schwab
Rebekka A. Schwab
JNJadwiga Nieminuszczy
Jadwiga Nieminuszczy
FSFenil Shah
Fenil Shah
JLJamie Langton
Jamie Langton
DMDavid Lopez Martinez
David Lopez Martinez
WNWojciech Niedzwiedz
Wojciech Niedzwiedz
DNA replication stress can cause chromosomal instability and tumor progression. One key pathway that counteracts replication stress and promotes faithful DNA replication consists of the Fanconi anemia (FA) proteins. However, how these proteins limit replication stress remains largely elusive. Here we show that conflicts between replication and transcription activate the FA pathway. Inhibition of transcription or enzymatic degradation of transcription-associated R-loops (DNA:RNA hybrids) suppresses replication fork arrest and DNA damage occurring in the absence of a functional FA pathway. Furthermore, we show that simple aldehydes, known to cause leukemia in FA-deficient mice, induce DNA:RNA hybrids in FA-depleted cells. Finally, we demonstrate that the molecular mechanism by which the FA pathway limits R-loop accumulation requires FANCM translocase activity. Failure to activate a response to physiologically occurring DNA:RNA hybrids may critically contribute to the heightened cancer predisposition and bone marrow failure of individuals with mutated FA proteins.

1 July 2010 in Cell
Verified
Journal Article
Closed access
CMCraig MacKay
Craig MacKay
ADAnne-Cécile Déclais
Anne-Cécile Déclais
CLCecilia Lundin
Cecilia Lundin
AAAna Agostinho
Ana Agostinho
ADAndrew J. Deans
Andrew J. Deans
JRJohn Rouse
John Rouse

1 December 2009 in Molecular Cell
Verified
Journal Article
Closed access
ADAndrew J. Deans
Andrew J. Deans
SWStephen West
Stephen West

6 May 2014 in Annual Review of Biophysics
Verified
Journal Article
Closed access
HWHelen Walden
Helen Walden
ADAndrew J. Deans
Andrew J. Deans
Mutations in any of at least sixteen FANC genes (FANCA–Q) cause Fanconi anemia, a disorder characterized by sensitivity to DNA interstrand crosslinking agents. The clinical features of cytopenia, developmental defects, and tumor predisposition are similar in each group, suggesting that the gene products participate in a common pathway. The Fanconi anemia DNA repair pathway consists of an anchor complex that recognizes damage caused by interstrand crosslinks, a multisubunit ubiquitin ligase that monoubiquitinates two substrates, and several downstream repair proteins including nucleases and homologous recombination enzymes. We review progress in the use of structural and biochemical approaches to understanding how each FANC protein functions in this pathway.

28 May 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBruno Silva
Bruno Silva
RPRichard Pentz
Richard Pentz
AFAna Margarida Figueira
Ana Margarida Figueira
RARajika Arora
Rajika Arora
YLYong Woo Lee
Yong Woo Lee
CAClaus Azzalin
Claus Azzalin
Telomerase negative immortal cancer cells elongate telomeres through the Alternative Lengthening of Telomeres (ALT) pathway. While sustained telomeric replicative stress is required to maintain ALT, it might also lead to cell death when excessive. Here, we show that the ATPase/translocase activity of FANCM keeps telomeric replicative stress in check specifically in ALT cells. When FANCM is depleted in ALT cells, telomeres become dysfunctional, and cells stop proliferating and die. FANCM depletion also increases ALT-associated marks and de novo synthesis of telomeric DNA. Depletion of the BLM helicase reduces the telomeric replication stress and cell proliferation defects induced by FANCM inactivation. Finally, FANCM unwinds telomeric R-loops in vitro and suppresses their accumulation in cells. Overexpression of RNaseH1 completely abolishes the replication stress remaining in cells codepleted for FANCM and BLM. Thus, FANCM allows controlled ALT activity and ALT cell proliferation by limiting the toxicity of uncontrolled BLM and telomeric R-loops.